It has been established that nuclear factor kappa-light-chain-enhancer of activated B cells (NF-jB) members promote survival by upregulating antiapoptotic genes and that genetic and pharmacological inhibition of NF-jB is required for tumor necrosis factor (TNF)-induced hepatocyte apoptosis. In this study, we demonstrate that this pro-survival pathway is switched to proapoptosis under pyruvate dehydrogenase kinase 4 (PDK4)-deficient conditions. PDK4-deficiency triggered hepatic apoptosis concomitantly with increased numbers of aberrant mitochondria, reactive oxygen species (ROS) production, sustained c-Jun N-terminal Kinase (JNK) activation, and reduction of glutathione (GSH). Interestingly, PDK4 retained p65 in cytoplasm via a direct protein-protein interaction. Disruption of PDK4-p65 association promoted p65 nuclear translocation. This, in turn, facilitated p65 binding to the TNF promoter to activate TNF-TNFR1 apoptotic pathway. Pdk4 2/2 livers were sensitized to Jo2 and D-(1)-Galactosamine /Lipopolysaccharide (GalN/LPS)-mediated apoptotic injury which was prevented by the inhibition of p65 or TNFR1. The pro-survival activity of TNF was shifted, which was switched to a pro-apoptotic activity in Pdk4 2/2 hepatocytes as a result of impaired activation of pro-survival NF-jB targets. Conclusion: PDK4 is indispensable to dictate the fate of TNF/NF-jB-mediated hepatocyte apoptosis. (HEPATOLOGY 2018; 68:1111-1124).
P yruvate dehydrogenase kinase 4 (PDK4) acts to inactivate the pyruvate dehydrogenase complex by phosphorylating the pyruvate dehydrogenase (PDH), thereby dictating the conversion of acetylcoenzyme A (Acetyl-CoA) from pyruvate.
(1) The primary research focus over the past decade has been on PDK4-related metabolic functions (2) ; however, emerging evidence suggests a pleotropic role of PDK4 in promoting tumorigenesis. (3) A recent report reveals that PDK4 activates mothers against decapentaplegic homolog 1/5/8 (SMAD1/5/8) by phosphorylation and is dual-localized in the cytosol and mitochondria. (4) Investigating PDK4's noncanonical function and its crosstalk with cytosol molecules would greatly expand the understanding of its regulatory roles in human diseases.
The two apoptotic pathways are the intrinsic mitochondrion-dependent pathway and the extrinsic apoptosis pathway. (5) The intrinsic pathway can be activated by DNA damaging agents, stress, hypoxia, and reactive oxygen species (ROS). The extrinsic pathway is at least partially mediated by tumor necrosis factor (TNF) binding to its receptors. TNF receptor activation leads to recruitment of different adaptor proteins. These death adaptors, in turn, couple with cell death effectors (e.g., pro-caspase-8 and pro-caspase-10), form the death-inducing signaling complex and generate an apoptotic signaling cascade initiated by the cleavage and activation of caspases. (6) Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-jB) family of transcription factors exist as a homodimer or heterodimer consisting of various combinations of its family members. In resting cells, NF-jB proteins reside in the cytoplasm in an inactive form, bound by members of the inhibitory IjB family. For the canonical (classical) NF-jB pathway, the activating signaling molecules, including TNF and interleukin-1 b, can be mediated through the tumor necrosis factor receptor (TNFR) and interleukin-1 receptor, respectively. These trigger p65/ p50 nuclear translocation and binding to target gene promoters. (7) The NF-jB signaling pathway is particularly relevant to liver diseases including hepatitis, liver fibrosis, and hepatocellular carcinoma (HCC). (8) The intriguing interplay between NF-jB and TNF has been implicated in hepatocytes. TNF elicits distinct responses by positively modulating liver regeneration (9) and inducing cell death during hepatotoxic injury. (10) Interestingly, NF-jB inhibition converts the effect of TNF response from proliferation to apoptosis in a hepatocyte cell line. (11) Although it is well known that NF-jB is a family of cell survival transcription factors by upregulating antiapoptotic genes, the role of NF-jB as a double-edged sword in mouse hepatocytes injury and HCC development has been reported. (8, 12) New signaling molecules to convey the crosstalk between NF-jB and TNF remain to be uncovered.
PDK4 expression was downregulated in human HCC specimens and several key cell cycle regulators were upregulated in livers of Pdk4 2/2 mice. (13) Because cell proliferation and apoptosis are the opposite processes to control a cell fate, we aimed at understanding the role of PDK4 in cellular apoptosis in this study. Unexpectedly, we discovered an essential role of PDK4 as a checkpoint to dictate the fate of hepatocyte apoptosis by mediating the crosstalk between NF-jB and TNF.
Materials and Methods
Wild-type (WT) and Pkd4 2/2 mice (13) were handled in accordance with a protocol approved by the Institutional Animal Care and Use Committee at the University of Connecticut (UConn). All mice were of C57BL/6J (inbred strain) genetic background and were housed under the same conditions at the UConn animal facility. Detailed breeding information about WT and Pdk4 2/2 mice is provided in the Supporting Information. Anti-Mouse cluster of differentiation 95 ([CD95] Jo2) (#554255; BD Pharmingen) was diluted in phosphate-buffered saline (PBS). Two-month-old male mice were intravenously (tail) injected with plasmids (50 lg per mouse) using TurboFect in vivo Transfection reagent (#R0541; Thermo Fisher Scientific). Three days after injection, mice were injected intraperitoneally with Jo2 and sacrificed at different time points. (5) We used an established D-(1)-Galactosamine/Lipopolysaccharide (GalN/LPS) apoptotic injury model. (14) Primary hepatocytes isolation and culture, liver histology, Western blot, immunofluorescence and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining were conducted as described. (15) (16) (17) (18) (19) Flow cytometry, Coimmunoprecipitation (Co-IP), glutathione S-transferase (GST) pull-down, Chromatin immunoprecipitation-Quantitative PCR (CHIPqPCR), qPCR, and luciferase reporter assay were reported. (20) (21) (22) (23) (24) (25) (26) For additional and detailed experimental procedures and statistical analysis please refer to Supporting Information.
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Results
KNOCKDOWN OF PDK4 IN HCC CELLS DECREASED CELL VIABILITY BY INDUCING APOPTOSIS
We generated in vitro HCC cell models with PDK4 knockdown. The PDK4 mRNA and protein were reduced by two small hairpin RNAs ([shRNAs] shPDK4 #1 and #2) in Huh7 and Hep3B cells with a similar knockdown efficacy (Supporting Fig. S1 ). Following PDK4 knockdown, cell viability (steady-state cell number) was evaluated for 6 days by MTS assay, which revealed noticeably lower cell numbers in shPDK4 #1 and #2 cells versus control shRNA (shCTL) cells (Fig.  1A) . Foci formation assay revealed that loss of PDK4 drastically inhibited Huh7 and Hep3B cells formation of colonies (Fig. 1B) . Poly (ADP-ribose) polymerase (PARP) protein cleavage is a marker of activated apoptosis. No cleaved PARP proteins were detected in shCTL cells, however they were strikingly induced in shPDK4 cells (Fig. 1C) . Caspases are the central components of apoptotic response. The activities of effector caspase-3, as well as the initiator caspase-8 and caspase-9, were all induced in shPDK4 cells (Fig. 1D ), suggesting that both extrinsic and intrinsic pathways were activated. Caspase-3 inhibitor and pan-caspase inhibitor completely blocked shPDK4-induced apoptosis, while caspase-8 inhibitor and caspase-9 inhibitor partially rescued it (Supporting Fig. S2A-C) . We determined the apoptotic rate using flow cytometry. In comparison with shCTL Huh7 or Hep3B cells, the early apoptotic (Annexin V-FITC1 /PI -, lower right quadrant of each plot) and late apoptotic/necrotic (Annexin V-FITC 1 / PI 1, upper right quadrant of each plot) cells were markedly increased in shPDK4 cells (Fig. 1E) . Taken together, the results demonstrated that loss of PDK4 function induced cellular apoptosis.
KNOCKDOWN OF PDK4 IN HCC CELLS DISRUPTED MITOCHONDRIAL FUNCTION AND RESPIRATION
A diagram elucidated when various assays were performed in shPDK4 cells (Supporting Fig. S3A ). Although massive apoptosis occurred during the first week of PDK4 knockdown, some cells survived despite maintaining 50% PDK4-depletion (Supporting Fig.  S3B ). Because shPDK4 #1 and #2 in Huh7 and Hep3B cells produced similar apoptotic phenotype (Fig. 1) , shPDK4 #2 Huh7 cells were used for further analysis.
Transmission electron microscope (TEM) revealed that shPDK4 cells displayed chromatin fragmentation and condensation (Fig. 1F , panel a; blue arrows), a characteristic morphologic manifestation of apoptosis. TEM also revealed increased mitochondria numbers in shPDK4 versus shCTL cells. Some mitochondria in shPDK4 cells lost clear edges (yellow arrows), whereas others showed enlarged cavities as vacuoles (green arrows). In addition, the mitochondrial cristae were distorted and swollen (red arrowheads) in shPDK4 cells compared with control cells. In addition, oneyear-old Pdk4 2/2 hepatocytes were enriched with lipid droplets and displayed enlarged endoplasmic reticulum (ER) cavity and increased lysosome number (Supporting Fig. S4A,B) .
The Seahorse assay (Supporting Fig. S5 ) was used to determine mitochondria respiration. The basal respiration, maximal respiration, spare respiratory capacity, and the percentage of spare respiratory capacity were all significantly increased in shPDK4 versus shCTL cells (Fig. 1F, panel b; Supporting Fig. S6A ). Interestingly, mitochondrial membrane potential (Dwm) was decreased in apoptotic cells, but was maintained, even with moderate increasing, in surviving cells (Supporting Fig. S7A ). The expression of mitochondria biogenesis regulator PGC1a was not altered in shPDK4 cells (Supporting Fig. S7B ). However, the cellular reactive oxygen species (ROS) levels were highly increased in shPDK4 versus shCTL cells (Fig. 1F, panel c) , demonstrating that PDK4 knockdown led to oxidative stress. Corresponding to potentiated ROS production, we examined five electron leakage sites based on mitochondrial superoxide/H 2 O 2 production in Amplex UltraRed Assay and found that the sites III Qo and mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) were disturbed with more electron leakages in shPDK4 cells comparing with shCTL cells (Supporting Fig. S7C ).
We further measured cellular PDH activities in shCTL and shPDK4 cells cultured under normal (N) or low (L) glucose concentrations (Fig. 1F, panel d) . In shCTL cells, low glucose increased PDH activity, which may be a compensatory response. However, PDH activity remained at constant high levels in shPDK4 cells. The higher PDH activity rendered by down-regulation of PDK4 corresponded to the lower nicotinamide adenine dinucleotide (NAD/NADH ratio) (Supporting Fig. S6B ), suggesting enhanced NADH production. Collectively, the results suggested that loss of PDK4 function in HCC cells disrupted mitochondria function and induced apoptosis.
DIMINISHING PDK4 EXPRESSION ACTIVATED TNF PATHWAY BY INDUCING NF-jB NUCLEAR TRANSLOCATION
To define the cell signaling pathways leading to apoptosis after PDK4 knockdown, 84 key genes from cell death pathways (including apoptosis, autophagy, and necrosis) were simultaneously assayed using the RT Interestingly, TNF, baculoviral IAP repeat-containing protein 3 (BIRC3, also named c-IAP2), and coiledcoil domain-containing protein 103 (CCDC103) were found commonly upregulated in shPDK4 Huh7 and Hep3B cells ( Fig. 2A) with TNF showing the highest elevation (125-fold in Huh7 and 64-fold in Hep3B). The induction of TNF, BIRC3 and CCDC103 mRNA in shPDK4 cells was validated by qPCR (Fig. 2B) . Enzyme-linked immunosorbent assay (ELISA) also detected increased TNF protein in cell culture supernatants (secreted form) and in cell lysates (cellular form) in shPDK4 cells (Fig. 2C) . Notably, the cellular form of TNF was more highly induced than the secreted form.
Given that BIRC3 and TNF, both of which are NF-jB target genes, (27) were upregulated in shPDK4 cells, we examined the activity of NF-jB pathway mediated by p65 nuclear translocation. The p65 protein was highly enriched in the nuclear fraction of shPDK4 versus shCTL cells (Fig. 2D) . Immunofluorescence staining further revealed an enhanced p65 nuclear translocation in shPDK4 cells (Fig. 2E) . We next performed ChIP assay using sheared chromatin (Supporting Fig. S9A ), which detected a marked increase of p65 occupancy in TNF and BIRC3 promoters (Fig. 2F, Supporting Fig. S9B) . Interestingly, the CCDC103 gene promoter was also bound by significant amount of p65, suggesting CCDC103 as a new target of the canonical NF-jB signaling. Further, the p65 occupancy on the promoter of c-FLIP, a wellknown target of NF-jB, was also increased (Supporting Fig. S9C ). Taken together, the results demonstrated that diminishing PDK4 expression resulted in activation of the NF-jB/TNF signaling pathway. 
PDK4 INTERACTED WITH NF-KB/ P65 TO REGULATE CANONICAL NF-jB SIGNALING
To gain molecular insights into the function of PDK4 in NF-jB signaling, we determined whether PDK4 was associated with p65. Confocal imagining of the subcellular localization of PDK4 and p65 in Huh7 cells revealed a colocalization of both proteins in cytoplasm, which was partially overlapped with the mitochondria marker Mitored (Fig. 3A) . Coimmunoprecipitation (Co-IP) identified an interaction of PDK4 with p65 but not with the proliferating cell nuclear antigeph.DMRn (PCNA) protein in Huh7 cells (Fig. 3B, left) . The endogenous interaction between PDK4 and p65 was also observed in both cytosolic and mitochondrial compartments but not in nuclear extracts in Hepa1 cells (Fig. 3B, right) . GST pulldown assay further confirmed a direct physical interaction between p65 protein and GST-PDK4 fusion protein (Fig. 3C) . Thus, PDK4 protein bound to the NFjB p65 subunit.
Next, we asked whether PDK4 functionally responded to NF-jB activation. Given that loss of PDK4 induced cellular ROS accumulation (Fig. 1F, panel c) , we (Fig. 3D, left) . When cells were deprived of glucose for 48 hours, the interaction of PDK4 and p65 was also impaired (Fig. 3D,  right) . Deprivation of glutamine showed a minimal effect. Thus, knockdown of PDK4 resulted in increased ROS production, which in turn further disrupted the PDK4 and p65 protein interaction. Such events released p65 to facilitate its nuclear translocation. To further identify the NF-jB subunits that mediate NF-jB activation in the absence of PDK4, we performed immunoprecipitation in shPDK4 Huh7 cells; p65 interacted with RELB, C-Rel, p50 and p52, and p65-p50 and p65-RELB interactions were potentiated under PDK4 knockdown condition (Supporting Fig. S9D ). The Re-CHIP assay revealed that p65 co-occupied TNF promoter predominantly with p50, and to a less extent with RELB and C-Rel (Supporting Fig. S9E ). These results indicated that p50 served as the primary binding partner of p65 in the absence of PDK4.
Considering TNF and lipopolysaccharide (LPS) as potent NF-jB signaling activators, we examined the crosstalk between PDK4 and TNF/LPS in regulating the NF-jB signaling. Overexpression of PDK4 did not alter basal p65 activity but markedly attenuated its stimulation by TNF and LPS in Huh 7 cells (Fig. 3E) , suggesting PDK4 was able to sequester NF-jB. We constructed TNF, BIRC3 and CCDC103 promoter luciferase reporters, all of which contain the NF-jB/ p65 binding site (Supporting Fig. S10A ). As expected, the promoters of TNF, BIRC3 and CCDC103 were activated by p65 overexpression, which were suppressed by coexpressing PDK4 in a dose-dependent manner (Fig. 3F) . Single NF-jB site mutation partially decreased p65-mediated TNF, BIRC3 and CCDC103 promoter activities (Supporting Fig. S10B ) whereas mutation of all sites completely blocked p65 transactivation (Fig. 3F) . Taken together, the results suggested that PDK4 functionally restrained the activation of NF-jB signaling.
INHIBITION OF NF-jB/TNF SIGNALING PREVENTED SHPDK4-INDUCED APOPTOSIS
Since BIRC3 encodes a member of the IAP (Inhibitor of Apoptosis) family of proteins that inhibit apoptosis, (30) whereas CCDC103 is a dynein arm attachment factor involved in necrotic cell death response, (31) we hypothesized that the induction of TNF in shPDK4 cells may play a major role in PDK4-mediated cell death, considering its established proapoptotic function. (32) To test this hypothesis, we generated shPDK4 Huh7 cells with simultaneous knockdown of TNF receptors (TNFR1, TNFR2), BIRC3, or CCDC103 (Fig. 4A) . TNFR1 is ubiquitously expressed whereas TNFR2 is mainly expressed in immune cells. (6) Consistently, we found that TNFR1, but not TNFR2, was expressed in Huh7 cells (Fig. 4A) . Loss of TNFR1 largely prevented apoptotic cell death in shPDK4 cells, whereas knockdown of BIRC3 and CCDC103 had no major effect (Fig. 4B) . Similarly, ablation of NF-jB activation by knocking down p65 (Fig. 4C ) significantly impaired shPDK4-induced apoptosis (Fig. 4D) . Therefore, our loss of function studies demonstrated that the activation of NF-jB/TNF signaling was responsible for shPDK4-induced apoptosis in HCC cells.
PDK4
2/2 HEPATOCYTES WERE SUSCEPTIBLE TO OXIDATIVE INSULT AND APOPTOSIS INDUCERS
To illustrate whether Pdk4-deficient hepatocytes are susceptible to apoptosis, we isolated primary hepatocytes from WT and Pdk4 2/2 mice and treated the cells with H 2 O 2 (intrinsic pathway inducer) and TNF (extrinsic pathway inducer). Pdk4 2/2 hepatocytes were more sensitive to H 2 O 2 with respect to cell viability, as the cells showed significantly lower IC50 (H 2 O 2 : Pdk4 2/2 162.5 lM versus WT 294.3 lM) (Fig. 4E) . Similarly, when hepatocytes were challenged with cycloheximide (CHX) to sensitize TNF's efficacy, Pdk4 2/2 hepatocytes were more susceptible to TNF (IC50: Pdk4 2/2 10.9 ng/mL versus WT 24.4 ng/mL). These were accompanied by the increased caspase-3, caspase-8 and caspase-9 activities in Pdk4 2/2 versus WT hepatocytes (Fig. 4F) . Therefore, loss of PDK4 function sensitized hepatocytes to apoptotic stimuli.
ECTOPIC EXPRESSION OF PDK4 PROTECTED LIVER FROM JO2-INDUCED APOPTOSIS BY RESTRAINING NF-jB/TNF ACTIVATION
To elucidate the contribution of PDK4 in regulating apoptosis in vivo, we used an acute liver injury model, Fas (CD95)-mediated liver apoptosis. (33) Eight-weekold WT mice were intravenously injected with empty vector (EV) or PDK4 overexpression plasmid. After 3 days, PDK4 overexpression in mouse liver was validated by Western blot (Fig. 5A, panel a) . Mice were then intraperitoneally injected with an anti-Fas agonistic antibody Jo2 (10 lg/mouse). Six hours after Jo2 administration, EV livers became macroscopically hemorrhagic and swollen, whereas PDK4 livers showed significant protection (Fig. 5A, panel b) . Hematoxylin and eosin (H&E) staining revealed that Jo2 treatment led to extensive red blood cell infiltration in EV livers, which was to a much less extent in PDK4 overexpressed livers (Fig. 5A, panel c) . The Jo2 antibody showed lethal effect in WT mice. (33) PDK4 overexpression significantly increased the viability of mice challenged with Jo2 (Fig. 5A, panel d) . The plasma alanine aminotransferase (ALT) levels were also alleviated in PDK4 overexpressed mice (Supporting Fig. S11 ), suggesting a protective effect. TUNEL staining further revealed decreased hepatic apoptosis in PDK4 versus EV mice (Fig. 5B, panel a) . Consistently, caspase-3 activation (Fig. 5B, panel b) , PARP and BH3-interacting domain death agonist (BID) cleavage, and Cytochrome C and Smac/DIABLO release (Fig. 5B, panel c) were markedly diminished by PDK4 overexpression comparing with EV mice, which was accompanied by the alleviated ROS production (Fig. 5C ). Because ROS acts as a potent NF-jB activator, (34) we examined NF-jB/p65 nuclear . (F) Caspase-3, -8 and -9 activities in WT and Pdk4 2/2 primary hepatocytes treated with H 2 O 2 (300 lM) or TNF (25 ng/mL) for 24 hours. Data are shown as mean 6 SEM. *P < .01 versus WT. E, F: 10 lg/mL CHX was used to sensitize the apoptosis-inducing effect of TNF. translocation in Jo2-treated EV and PDK4 livers. Jo2 induced p65 nuclear protein as well as its activity in EV livers, which were significantly decreased in PDK4 livers (Fig. 5D) . Consistently, Jo2-induced TNF levels were largely reduced by PDK4 overexpression (Fig.  5E ). Taken together, the results demonstrated that ectopic expression of PDK4 protected liver from Jo2-induced apoptosis by impeding NF-jB/p65-TNF activation.
KNOCKDOWN OF P65 AND TNFR1 ALLEVIATED HEPATIC APOPTOSIS IN PDK4
2/2 MICE
To determine the direct effect of NF-jB/p65-TNF signaling in PDK4-mediated apoptosis, loss-offunction rescue studies were performed in Pdk4 2/2 mice with liver specific knockdown of p65 or TNFR1 (Fig. 5F, panel a) . Mice were intravenously injected mice were injected with control (shCon), shp65, or shTNFR1 plasmids via tail vein. Three days after transfection, mice were injected with Jo2 (5 lg/mouse) and livers were collected 6 hours later. B-F: Each group represents a pooled sample (equal amounts of protein) from 5 individual mice with triplicate assays. Data are shown as mean 6 SEM. C, D, E: *P < .01 versus EV-PBS; # P < .01, PDK4-Jo2 versus EV-Jo2. F: *P < .01 versus WT; # P < .01 versus Pdk4 2/2 1 shCon. Obj., objective.
with control, shp65, or shTNFR1 plasmids for 3 days, followed by administrating with a reduced dose of Jo2 (5 lg/kg body weight) for 6 hours to mitigate its toxicity. Both shp65 and shTNFR1 reduced Jo2-induced PARP protein cleavage (Fig. 5F, panel a) . As revealed by TUNEL staining, Jo2 caused more severe apoptosis in Pdk4 2/2 versus WT livers and in vivo knockdown of p65 or TNFR1 in Pdk4 2/2 mice significantly alleviated hepatic sensitivity to Jo2 (Fig. 5F, panel b) . The hepatic caspase-3 activation was similarly diminished by knockdown of either p65 or TNFR1 in Pdk4 2/2 mice livers (Fig. 5F, panel c) .
PDK4-DEFICIENCY FACILITATED WHEREAS OVEREXPRESSION OF PDK4 PROTECTED LIVER AGAINST GALN/ LPS-INDUCED APOPTOTIC INJURY
D-galactosamine (GalN)/LPS administration induces apoptotic liver injury specifically confined to hepatocytes, (18) which was applied to WT, Pdk4 2/2 and PDK4 overexpression (PDK4) mice. Gross liver morphology (Fig. 6A, panel a) and H&E staining ( , which was protected in PDK4 mice. The severity of injury in Pdk4 2/2 livers corresponded to short survival time (Fig. 6A, panel c) , high serum ALT levels (Fig. 6B ) and increased caspase-3 cleavage (Fig. 6C) . In addition, increased hepatic NF-jB/p65 activity and enhanced TNF and ROS production (Fig. 6D, panels a-d) , decreased hepatic glutathione (GSH) levels and sustained c-Jun N-terminal Kinase (JNK)/c-Jun activation (Fig. 6E , panels a,b) were observed in Pdk4 2/2 mice. Remarkably, these changes were reversed in PDK4 mice. Furthermore, knockdown of p65 and TNFR1 in Pdk4 2/2 livers decreased GalN/LPS-induced apoptosis (Fig.  6F, panel a) which correlated with the reduced TNF levels (Fig. 6F, panel b) .
PDK4-DEFICIENCY SHIFTED PRO-SURVIVAL FUNCTION OF NF-jB TO APOPTOSIS
It is well established that NF-jB has strong prosurvival effects through activating pro-survival genes. (23) We conducted additional experiments to address this paradox, given that NF-jB was activated however apoptotic death occurred in Pdk4-deficient cells. We first analyzed the expression of pro-apoptotic proteins in the presence of TNF stimulation. TNF alone induced caspase-3 activation, PARP and BID cleavage, and Cytochrome C and Smac/DIABLO release in Pdk4 2/2 , but not in WT primary hepatocytes (Fig. 7A, left) . Similar results were observed in shPDK4 versus shCTL cells ( Fig. 7A, right) . TNF stimulation also aggravated the apoptosis in shPDK cells. When TNF was combined with CHX, a protein translation inhibitor sensitizing cells to TNF-induced apoptosis, pro-apoptotic proteins were induced or cleaved in WT hepatocytes, but to a stronger extent in Pdk4 2/2 hepatocytes (Fig. 7A, middle) . In contrast, TNF-induced the expression of several pro-survival proteins including A20, c-IAPs and c-FLIP, in WT hepatocytes and shCTL cells (Fig. 7B ), whereas such effect was largely impaired in Pdk4 2/2 hepatocytes and shPDK4 cells. At the mRNA levels, the activation of pro-survival targets of NF-jB by TNF was also impaired under Pdk4-deficient conditions (Supporting Fig. S12) . Consistent with the in vivo results (Fig. 6E) , a sustained JNK activation was observed in Pdk4 2/2 hepatocytes and shPDK4 HCC cells (Fig. 7C) . On the other hand, reduced GSH levels were observed in PDK4-deficient cells (Fig. 7D ).
Discussion
As a metabolic switch of glucose oxidation and the tricarboxylic acid cycle (TCA cycle), the role of PDK4 beyond metabolism remains elusive. In this study, we reveal that PDK4 is essential for TNF to execute its pro-survival function via NF-jB and that Pdk4-deficiency shifts this antiapoptosis pathway toward proapoptosis (Fig. 8) .
We show that depletion of PDK4 in HCC cells induces spontaneous apoptotic cell death, which is accompanied by the disruption of mitochondria morphology and generation of ROS (Fig. 1) . TNF expression is upregulated by Pdk4-deficiency, which can be attributed to the increased p65 nuclear translation and binding to the TNF promoter to activate it (Fig. 2) . The activation of NF-jB-TNF pathway is responsible for shPDK4-induced apoptosis because knockdown of TNFR1 or p65 rescues cells from apoptotic death (Fig.  4) . At the molecular level, we find that PDK4 binds to p65 under normal conditions and that ROS or glucose-depletion dissociates p65 from PDK4 protein, facilitating its release to the nucleus (Fig. 3) . Using in vivo models, we show that Pdk4 2/2 liver is sensitized to liver injury with sustained JNK activation and GSH depletion. Overexpression of PDK4 prevents Jo2-and GalN/LPS-induced liver injury and apoptosis, which interacts with NF-jB/p65 and sequesters p65 in the cytoplasm. Mitochondria respiration and ROS production remain normal. TNF treatment can activate NF-jB (p50/p65 complex) signaling to promote the induction of pro-survival genes. Knockdown of PDK4 disrupts mitochondria respiration and generates excessive ROS; the latter facilitates PDK4 and p65 protein dissociation, and releases p65 to accelerate its nuclear translocation. Excessive ROS may also deplete cellular GSH and activate JNK. In this scenario, in the nucleus of PDK4-deficient cells, pro-survival genes are less/not responsive to p65 transactivation, whereas TNF is activated, which in turn induces caspase-8 and the extrinsic apoptosis pathway. In addition, ROS leads to activation of caspase-9 and the intrinsic apoptosis pathway. Collectively, we propose that increased ROS, decreased GSH, and sustained JNK activation shift the pro-survival function NF-jB toward facilitating TNF-mediated apoptosis. IKK, IjB kinase.
is associated with reduced hepatic ROS levels, p65 nuclear translocation, NF-jB activities and TNF production. In contrast, knockdown p65 or TNFR1 largely protects Pdk4 2/2 liver from undergoing apoptosis (Figs. (5 and 6) ). From these results, we conclude that the activation of NF-jB/TNF signaling promotes apoptosis under Pdk4-deficient conditions. TNF can activate NF-jB to antagonize its deathinducing signaling. Our findings are not mutually exclusive with the previous notion that NF-jB activation is a survival mechanism that protects hepatocytes from TNF-mediated apoptosis by inducing prosurvival genes. (35) We propose that NF-jB activation is not necessarily pro-survival, per se, but rather depends on the expression profile mediated by its activation. Further in-depth analyses show that the prosurvival activity of TNF is impaired, which is switched to a pro-apoptotic activity in Pdk4 2/2 hepatocytes (Fig. 7) . These findings suggest that NF-jB activation is more than a simple on/off and is subjected to complex regulations. Sustained JNK activation (36, 37) and glutathione depletion (38, 39) may both contribute to TNF-induced apoptosis under Pdk4-deficient conditions. JNK activation amplifies ROS generation (40) and the latter further enhances JNK activity, (41) formatting a positive feedback loop to facilitate apoptotic death. The degree of protection by shTNFR1 against shPDK4-induced apoptosis is stronger than by shp65, suggesting that a direct blocking of TNF signal transduction is critical to prevent shPDK4-induced apoptosis.
TNF is a pleiotropic cytokine that is mainly produced by activated macrophages, but also by hepatocytes, albeit a small amount. (42) In shPDK4 HCC cells, the increased NF-jB/p65 nuclear translocation and subsequently the activation of TNF not only induce caspase-8, but also the intrinsic pathway initiator caspase-9. The latter is likely partly trigged by the increased cellular ROS production, an inducer of NFjB and the intrinsic apoptosis pathway. (28) The numbers of aberrant mitochondria are significantly increased in shPDK4 cells, which may contribute to the sustained PDH activity and abnormal ROS production. Thus, ROS could be an intrinsic prerequisite for hepatic apoptosis triggered by loss of PDK4. It should be noted that GalN/LPS is a TNF-dependent model requiring NF-jB-dependent TNF production in liver nonparenchymal cells (NPC) to induce apoptosis in GalN-sensitized hepatocytes. Therefore, our results do not exclude the involvement of NPC in PDK-mediated regulation of TNF production. Intriguingly, the PDKs' pan-inhibitor dichloroacetate and PDK4's specific inhibitor diisopropylamine dichloroacetate (DADA) exhibit antitumor efficacy in breast cancer models by inducing cell death. (43) In this regard, PDK4 inhibitors might be particularly useful in triggering cell death in HCC and other cancers.
